Cargando…
Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial
Thirty years after its discovery, the hepatitis C virus (HCV) remains a leading cause of liver disease worldwide. Given that many countries continue to experience high rates of transmission despite the availability of potent antiviral therapies, an effective vaccine is seen as critical for the elimi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310243/ https://www.ncbi.nlm.nih.gov/pubmed/34372558 http://dx.doi.org/10.3390/v13071351 |